City

Boulogne-Billancourt (1)

Nanjing (1)

Pittsburgh (1)

Condition

Unresectable Colorectal Liver Metastases (3)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

David Bartlett (1)

Zhongda Hospital (1)

Collaborator

Sanofi (1)

The Pittsburgh Foundation (1)

Intervention

chemotherapy (1)

in situ immunotherapy (1)

oxaliplatin (1)

radiofrequency ablation (rfa) (1)

selective internal radiation therapy (sirt) with yttrium-90 carbon microspheres (1)

Study Documents

Intervention Type

drug (2)

combination product (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

unresectable colorectal liver metastases

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

Recruiting

Unresectable Colorectal Liver Metastases

Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres

Nanjing, Jiangsu, China

Zhongda Hospital Southeast University

Jan 26, 2023

Unresectable Colorectal Liver Metastases Trial in Boulogne-Billancourt (Chemotherapy, Radiofrequency ablation (RFA), In situ

Not yet recruiting

Unresectable Colorectal Liver Metastases

Chemotherapy
+2 more

Boulogne-Billancourt, France

Digestive Surgery Department, Ambroise Pare University Hospital,

Jun 14, 2021

Unresectable Colorectal Liver Metastases Trial in Pittsburgh (Oxaliplatin)

Completed

Unresectable Colorectal Liver Metastases

Oxaliplatin

Pittsburgh, Pennsylvania
+2 more

Dec 19, 2017